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Chromosome 15q11-q13.1 duplication is a common copy number variant associated
with autism spectrum disorder (ASD). Most cases are de novo, maternal in origin and
fully penetrant for ASD. Here, we describe a unique family with an interstitial 15q11.2-
q13.1 maternal duplication and the presence of somatic mosaicism in the mother. She
is typically functioning, but formal autism testing showed mild ASD. She had several
congenital anomalies, and she is the first 15q Duplication case reported in the literature
to develop unilateral renal carcinoma. Her two affected children share some of these
clinical characteristics, and have severe ASD. Several tissues in the mother, including
blood, skin, a kidney tumor, and normal kidney margin tissues were studied for the
presence of the 15q11-q13.1 duplication. We show the mother has somatic mosaicism
for the duplication in several tissues to varying degrees. A growth competition assay in
two types of stem cells from duplication 15q individuals was also performed. Our results
suggest that the presence of this interstitial duplication 15q chromosome may confer a
previously unknown growth advantage in this particular individual, but not in the general
interstitial duplication 15q population.
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INTRODUCTION
A 35-year-old female underwent clinical and neuropsychiatric evaluation after her two affected
sons, who have maternal interstitial 15q11.2-q13.1 duplication (int dup15) (Figure 1: IV-1 and IV-
2) were seen at Le Bonheur Children’s Hospital. The mother was born with a unilateral preauricular
pit. A sacral dermoid cyst, a large hemangioma on the left forearm, and another on the left inner
thigh that were removed in childhood. She has a history of learning disabilities and attention deficit
hyperactivity disorder. She graduated from high school and is currently a stay at home mom. At
age 30, precancerous colonic polyps were removed. At 33 years of age she had a right subtotal
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FIGURE 1 | Family history. I-3 had prostate cancer and died at 83 years old. I-4 developed Kaposi sarcoma and died at 83 years old. II-3 had precancerous
polyps and was negative for int dup15. III-4 was negative for int dup 15. The proband, III-4, had birth defects, renal carcinoma, and presented polyps like her father
and passed the 15q duplication to her two sons, but not her daughter (IV-3). IV-1 has a maternal int dup15 and incomplete formation of the sacrum and coccyx and
a pilonidal sinus tract. IV-2 with maternal int dup15.
nephrectomy due to renal carcinoma chromophobe cell type.
A mild autism spectrum disorder (ASD) diagnosis was
established at 34 year of age by the Autism Diagnostic
Observation Schedule, Second Edition (ADOS-2) and Autism
Diagnostic Interview, Revised (ADI-R) (Lord et al., 1989, 1994).
She demonstrated an overall below average IQ of 75 on the
Wechsler Abbreviated Scale of Intelligence second edition but
there was significant discrepancy between reasoning domains
with a low average Verbal Comprehension Index of 89 and well
below average Perceptual Reasoning Index of 66.
She has a positive family history of cancer, including
a father with similar precancerous polyps, and an 83-year-
old maternal grandmother with Kaposi sarcoma, non-human
immunodeficiency virus related. A maternal grandfather died at
age 83 and had prostate cancer (Figure 1).
Fluorescence in situ hybridization (FISH) analysis was
performed (Signature Genomics, Spokane, WA, USA) on blood
and fibroblast cells. A probe specific for the 15q11.2-q13.1 region
(SNRPN gene) along with two control probes targeting the
chromosome 15 centromeric region (D15Z1) and the 15q22
region (PML gene) (Abbott Molecular, Abbott Park, IL, USA)
were used to label metaphase cells and interphase nuclei. The
results confirmed the presence of the 15q11.2-q13.1 duplication
and demonstrated a somatic mosaicism, with 61.6% of blood cells
and 67% of fibroblast cells containing the duplication (a total of
250 cells were assessed per sample).
Parent of origin testing by Methylation Sensitive-High
Resolution Melting (MS-HRM) curve analysis from blood DNA
of the differentially methylated region of the SNRPN gene
(Urraca et al., 2010) indicated that this duplication is maternal
in origin (Figure 2A). Her mild presentation suggested the need
for formal testing in other tissues. Blood and saliva produced
an identical signal to an interstitial maternal duplication control
sample from blood (Figure 2B). However, her fibroblasts showed
a slightly higher relative intensity than blood, reminiscent of
isodicentric duplications (Urraca et al., 2010; Scoles et al., 2011)
and possibly indicative of an increase in the number of copies
of the SNRPN locus (Figure 2B). Renal tumor tissue samples
were also analyzed. All tumor samples tested (N = 4) showed
the presence of a maternal duplication, while the normal kidney
margin samples from the same block (N = 4) showed a signal
intensity that matched the control sample (Figure 2C). These
results indicate that the faster growing tumor cells retained
the interstitial duplication chromosome, while the surrounding
normal tissues were predominantly non-duplication cells.
To determine if the int dup15 chromosome conferred a
growth advantage in the renal carcinoma cells, we analyzed
induced Pluripotent Stem Cells (iPSC) derived from her
fibroblasts. We obtained 16 clones that had methylation profiles
consistent with the presence of the duplication, and 2 clones
with reduced methylation. Karyotype analysis indicated that one
of the two clones with a normal karyotype was a mixed clone
containing iPSC with the duplication and non-duplicated cells.
The other clone appeared to be completely non-duplicated (20
cells analyzed). After repeated passage in the lab, the mixed iPSC
culture was overtaken by the duplication cells. Repeated attempts
to recover the iPSC with a normal karyotype from the mixed
culture failed. We hypothesized that the non-duplication cells
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FIGURE 2 | MS-HRM duplication analysis. (A) Blood samples from the proband (801-030) and her two affected sons (801-018 and 801-024) indicate the
presence of a maternal specific duplication with an increased relative signal for the methylated (bisulfite converted) allele (i.e., 2:1). Maternal UPD (100% methylated);
Neurotypical (55–65% methylated) and Paternal Duplication (35–45% methylated) controls are included for reference. (B) Survey of several tissues from the proband
(801-030) including blood, saliva and a fibroblast cell line all show the presence of the maternally duplicated allele. (C) Samples from normal kidney margin
co-localized with neurotypical control samples (n = 4) and samples from the tumor region co-localized with maternal duplication controls (n = 4).
were being overgrown by duplication cells in this individual.
To test this hypothesis, iPSC derived from an unrelated normal
control individual were mixed with her duplication cell line, with
a 1:1 ratio. In this mixed cultures, the unrelated normal karyotype
iPSC were more abundant than the duplication iPSC compared
to two different cell lines from the mother, indicating that the
int dup15 does not confer a growth advantage in cultured iPSC
(Table 1).
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TABLE 1 | Percentage of Dup15q Cells in Mixed induced Pluripotent Stem Cells (iPSC) and dental pulp stem cells (DPSC) Cultures.
Cell Line Combination Cell Type 15q Duplication 15q Triplication
Control + Mother Line 1 iPSC (38.5%) 77/200 cells None
Control + Mother Line 2 iPSC (11.2%) 15/132 cells None
Control 1+ Dup15q 1 DPSC (20.5%) 41/200 cells (34.5%) 69/200 cells
Control 2+ Dup15q 2 DPSC (6.5%) 13/200 cells (13.5%) 27/200 cells
Control 3 + Dup15q 3 DPSC (3.5%) 7/200 cells (1.5%) 3/200 cells
To further evaluate the growth rate of non-duplicated vs
duplicated cells in culture, Dental Pulp Stem Cells (DPSC)
from unrelated controls and int dup15 cases were examined.
Cells were mixed at 50:50 ratio and grown in vitro. The
duplication cells in each of three experiments using six unrelated
individuals consistently grew slower than the control cells
(Table 1). In addition, we identified in each culture that
1–35% of the cells had undergone additional chromosomal
rearrangements, resulting in triplication events (Figure 3).
These results indicate that int dup15 cells typically grow
slower than control cells in mixed culture from unrelated
individuals and that the duplication is unstable in cultured
DPSC.
Son IV-1 (801-018)
Born prematurely at 34 weeks. At birth weight was 2.3 kg
(60%) and 45 cm long (60%). He spent 5 days at the
NICU for respiratory distress and required oxygen. He
has a history of hypotonia and seizures from 6 weeks of
age, now under control with oxcarbazepine therapy. Early
motor and language developmental milestones were delayed.
He receives special education as well as speech-language,
occupational and physical therapy. Physical examination revealed
at midline a flat vascular birthmark on the forehead. Other
dysmorphic features include short palpebral fissures, long
eyelashes, bushy eyebrows, mild droopy eyelids, and mildly
lax facial features. He has hypotonia, a wide base to his
gait and a left in toeing. Magnetic Resonance Imaging (MRI)
of the brain was remarkable for periventricular leukomalacia.
Lumbar spine MRI revealed an incomplete formation of the
distal sacrum and coccyx and a tiny pilonidal sinus tract.
Newborn abdominal ultrasound showed a prominent renal pelvis
bilaterally.
The duplication status was determined by array comparative
genomic hybridization (aCGH). The platform used was Genome-
Wide Affymetrix SNP 6.0 array. The test confirmed the
presence of a ∼5 Mb duplication encompassing the Prader-
Willi/Angelman Syndrome (PWS/AS) critical region between
BP2-BP3. At 5 years of age, he was administered the ADOS-2,
Module 1. He had a Comparison Score of 10/10, suggesting a
FIGURE 3 | Representative Fluorescence in situ hybridization (FISH) images from mixed culture analysis. The aqua signal is probe D15Z1 located at the
centromere, the red signal is a probe for the SNRPN gene within the duplication and the green signal is a probe for PML located outside of the duplicated region
(internal control probe). Dashed circles indicate signals from a control chromosome, interstitial duplication and interstitial triplication chromosome.
Frontiers in Genetics | www.frontiersin.org 4 November 2016 | Volume 7 | Article 205
fgene-07-00205 November 23, 2016 Time: 18:29 # 5
Urraca et al. 15q Duplication and Renal Carcinoma
high level of ASD symptomology. He also met the diagnostic
algorithm cut-off score on the ADI-R. Scores were consistent
with clinical observations. On the abbreviated Stanford-Binet-
V he demonstrated impaired intellectual ability with an IQ
of 47.
Son IV-2 (801-024)
Born full term with a weight of 3.8 kg (50%) and length of 52 cm
(75%). At birth he presented with shoulder dystocia and difficulty
breathing requiring intubation. He recovered and required no
further treatment. Early motor and language development were
thought to be normal. At 2 years of age, arrayCGH confirmed the
same∼5 Mb interstitial duplication found in his brother. Physical
exam was positive for bilateral epicanthal folds, deep infraorbital
creases and horizontal palpebral fissures, long eyelashes, short
nose, flat nasal bridge, and a long philtrum. Lower extremity tone
was decreased bilaterally, but in his upper extremities tone was
increased and there was general joint laxity. He has near daily
anger outbursts, during which he becomes physically aggressive,
which is treated with risperidone. He attends a self-contained
special education school and receives occupational, physical,
and speech-language therapies. Brain MRI, echocardiogram
and renal ultrasound were normal. At age 3.5 years of age
he was administered the ADOS-2, Module 1 on which he
had a Comparison Score of 8/10, suggesting a high level of
autism-related symptomology. In addition, he met the diagnostic
algorithm cut-off score on the ADI-R. Findings were consistent
with clinical observations. On the Wechsler Preschool and
Primary Scale of Intelligence (WPPSI-IV) he demonstrated below
average IQ of 73; no discrepancy was noted between subdomains.
Daughter IV-3
She was evaluated during her 1st year of life. No developmental,
learning, or cognitive issues were reported. She was negative for
any known copy number variants and appears neurotypical.
BACKGROUND
One of the most common copy number variants associated
with ASD are duplications of the proximal arm of chromosome
15q11-q13.1 (Moreno-De-Luca et al., 2012; Al Ageeli et al., 2014)
which can occur as either as interstitial, and more commonly,
isodicentric duplications (Hogart et al., 2010). Widespread use
of clinical microarrays has increased the detection rate of the
smaller int dup15. Most individuals with int dup15 share the
common deletion breakpoints of PWS/AS and result from
a reciprocal non-allelic homologous recombination (NAHR)
event. In a study of fourteen int dup15 cases, we reported
that the phenotype includes mild facial anomalies, ASD, sleep
issues, hypotonia, developmental delay, and a characteristic EEG
variant (Urraca et al., 2013). We also confirmed in this cohort
a previously reported parent origin effect (Cook et al., 1997;
Schroer et al., 1998), while paternal duplication cases have
incomplete penetrance (Urraca et al., 2013).
Most cases of int dup15 are de novo and maternally derived
(Hogart et al., 2010). Given this maternal-specific effect and the
low penetrance for ASD in paternal duplication cases, it has
long been assumed that the few inherited int dup15 cases in
the literature result from a silent (paternal) interstitial duplicated
chromosome being passed on by the mother, resulting in a
maternally inherited duplication in the offspring (Cook et al.,
1997). Inherited int dup15 is rare, with only one published case
involving the inheritance of a maternal duplication from the
mother (Boyar et al., 2001), although some families with paternal
duplication inherited from the father have been documented
(Browne et al., 1997; Cook et al., 1997; Boyar et al., 2001; Veltman
et al., 2005; Urraca et al., 2013; Al Ageeli et al., 2014). However,
few cases of paternal duplication with developmental delay have
been reported (Mohandas et al., 1999; Mao et al., 2000; Veltman
et al., 2005).
DISCUSSION
This is an atypical family with a mother who is mosaic for
maternal 15q duplication, with congenital anomalies, mild ASD,
a history of unilateral renal cancer, and a positive family history
for cancer. This maternal duplication was passed on to two
affected children (IV-1 and IV-2). The anomalies and the renal
cancer in the mother may not be related to the duplication,
however, the two affected boys will be evaluated annually by
renal ultrasounds. This family does not meet specific criteria
for any familial tumor syndrome. Both affected boys presented
with developmental delay, ASD and typical dysmorphic features
previously described (Urraca et al., 2013), although IV-1 shares
the sacral anomaly with his affected mother. The mother is only
mildly affected cognitively, but still on the autism spectrum by
clinical observation and formal ADOS/ADI-R testing. The fact
that her FISH showed a significant decrease in the number of
duplicated cells in both blood and skin raises the possibility that
she may be mosaic for the duplication in the central nervous
system (CNS) as well, thus decreasing the severity of her autism
symptoms.
Here, we were able to evaluate both her normal and tumor
renal samples and were surprised to find that the tumor cells
consistently showed an int dup15 signal, while the surrounding
normal kidney margin cells showed a typical control signal
(Figure 2C). These results suggest that the faster growing tumor
cells are those with the duplication, despite the documented
somatic mosaicism. We tested the hypothesis that int dup15
cells grow faster than the non-duplicated cells in her iPSC
using a growth competition assay. Interestingly, her duplicated
cells grew faster than her normal cell line, however, when
we performed further growth competition experiments using
int dup15 iPSC and iPSC cells from non-duplicated unrelated
donors, we found that the duplicated iPSC grew slower than
the duplicated cells. Similar results were found when we
examined the growth of cultured DPSC from six unrelated
individuals (duplicated and non-duplicated) in a mixed culture
assay, with duplicated DPSC cells growing slower than non-
duplicated. It could be possible that the int dup15 confers
a growth advantage just within this individual. These results
imply that the 15q11.2-q13.1 duplication may not be the
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driving factor in the kidney tumor formation, but that some other
event in these cells caused them to be the prominent cell type in
the tumor cells versus normal kidney margin cells.
CONCLUDING REMARKS
Here, we described a unique family with maternal int dup15
and a demonstrated somatic mosaicism in the mother. An
extensive literature search also indicates that our proband is
the first case of int dup15 with renal cancer, which appears
coincidental since there is no apparent link between renal cell
carcinoma chromophobe subtype and duplications of 15q (Ren
et al., 2015). The mixed culture growth competition assays
in two types of stem cells, iPSC and DPSC, also indicated
that int dup15 cells typically grow slower than non-duplicated
controls. However, these in vitro experiments may not accurately
reflect the molecular and genetic events that occurred in the
mother which resulted in tumor cells with the duplication
and surrounding non-duplicated normal margin cells. Finally,
the fact that the mother was mildly affected but did not
display the full int dup15q phenotype implies that she may be
mosaic for the duplication in her CNS as well as blood and
skin.
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